Scout Investments Inc. Reduces Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Scout Investments Inc. trimmed its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 44.9% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,732 shares of the company’s stock after selling 27,473 shares during the quarter. Scout Investments Inc. owned approximately 0.06% of Molina Healthcare worth $13,634,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Molina Healthcare by 18.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 68,793 shares of the company’s stock valued at $28,262,000 after buying an additional 10,904 shares in the last quarter. Fortis Capital Advisors LLC purchased a new stake in Molina Healthcare in the 1st quarter valued at $370,000. State Board of Administration of Florida Retirement System grew its holdings in Molina Healthcare by 9.9% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 72,571 shares of the company’s stock valued at $29,814,000 after buying an additional 6,509 shares in the last quarter. Patton Fund Management Inc. purchased a new stake in Molina Healthcare in the 1st quarter valued at $4,338,000. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in Molina Healthcare by 92.7% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 76,447 shares of the company’s stock valued at $31,407,000 after buying an additional 36,769 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the sale, the director now owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO James Woys sold 10,000 shares of the stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total value of $3,451,500.00. Following the transaction, the chief operating officer now owns 53,613 shares in the company, valued at approximately $18,504,526.95. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ronna Romney sold 250 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the transaction, the director now owns 16,945 shares in the company, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on MOH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a report on Thursday, April 4th. JPMorgan Chase & Co. lowered their price target on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating for the company in a report on Wednesday, July 10th. Barclays lowered their price target on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating for the company in a report on Thursday, April 25th. Wells Fargo & Company lowered their price target on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating for the company in a report on Monday, April 29th. Finally, TD Cowen lowered their price target on Molina Healthcare from $453.00 to $412.00 and set a “buy” rating for the company in a report on Tuesday, April 30th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $403.20.

Molina Healthcare Trading Up 0.5 %

MOH traded up $1.58 during mid-day trading on Friday, hitting $289.32. 830,064 shares of the stock were exchanged, compared to its average volume of 452,313. The firm’s fifty day moving average is $312.59 and its two-hundred day moving average is $356.35. Molina Healthcare, Inc. has a 1-year low of $283.53 and a 1-year high of $423.92. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. The company has a market cap of $16.95 billion, a PE ratio of 15.65, a PEG ratio of 0.91 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. The company had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. Molina Healthcare’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same quarter last year, the company earned $5.81 EPS. Equities analysts forecast that Molina Healthcare, Inc. will post 23.56 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.